“A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the disorder with specific implications for treatment. The study found that individuals with this form of depression possess unique genetic risk profiles, experience different physical symptoms, and tend to respond less favorably to standard antidepressant medications. These findings were published in Biological Psychiatry.
Depression is often viewed by the general public as a single condition characterized by sadness and low energy. Mental health professionals and researchers recognize it as a complex and heterogeneous disorder with various trajectories. Patients often report vastly different symptoms and have uneven responses to available treatments. Some individuals find relief quickly with the first medication they try. Others struggle with chronic symptoms despite multiple interventions.
The scientific team behind this research aimed to address this variability by investigating the biological mechanisms driving these differences. They focused specifically on atypical depression. This subtype has been a subject of debate in psychiatry for over sixty years. It is historically characterized by a specific set of symptoms that differ from “melancholic” or typical depression.”
Read the full article at PsyPost